{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T11:22:31Z","timestamp":1793877751110,"version":"4.7.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T00:00:00Z","timestamp":1606262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Grants-in-Aid for Research from the National Center for Global Health and Medicine","award":["29-2001"],"award-info":[{"award-number":["29-2001"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>RA-associated interstitial lung disease (RA-ILD) is commonly associated with acute exacerbations (ILD-AE). This study examined the clinical characteristics and risk factors of ILD-AE and mortality of RA-ILD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We retrospectively collected data on 165 RA-ILD patients who visited or were admitted to our hospital between January 2007 and December 2019. We compared the clinical characteristics of patients who did and did not develop ILD-AE and identified variables significantly associated with ILD-AE. We also compared the admission characteristics of those who survived and those who died after admission for ILD-AE. ILD-AE was defined using previously proposed criteria, modified slightly for application to RA-ILD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The mean patient age was 73.6\u2009years (s.d. 9.7) and 97 (71.9%) patients were female. Thirty (22.2%) patients developed ILD-AE, 13 (43.3%) of whom died. In univariate analyses, neither the usual interstitial pneumonia (UIP) pattern nor MTX was associated with ILD-AE. In multivariate analyses, the UIP pattern was significantly associated with ILD-AE [odds ratio (OR) 2.55 (95% CI 1.05, 6.20), P\u2009=\u20090.038]. In the Cox proportional hazards model, the UIP pattern [hazard ratio (HR) 4.67 (95% CI 1.02, 21.45), P\u2009=\u20090.048] was significantly associated with death, while MTX use [HR 0.16 (95% CI 0.04, 0.72), P\u2009=\u20090.016] was significantly associated with survival.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Our data suggest that the UIP pattern is related to ILD-AE. Furthermore, both the UIP pattern and non-use of MTX might be related to death from ILD-AE in RA-ILD.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa608","type":"journal-article","created":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T19:39:23Z","timestamp":1598989163000},"page":"2348-2354","source":"Crossref","is-referenced-by-count":67,"title":["Acute exacerbation of rheumatoid arthritis\u2013associated interstitial lung disease: clinical features and prognosis"],"prefix":"10.1093","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9724-4911","authenticated-orcid":false,"given":"Shinji","family":"Izuka","sequence":"first","affiliation":[{"name":"Division of Rheumatic Diseases, National Center for Global Health and Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0022-1941","authenticated-orcid":false,"given":"Hiroyuki","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Division of Rheumatic Diseases, National Center for Global Health and Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arisa","family":"Iba","sequence":"additional","affiliation":[{"name":"Department of Public Health, Graduate School of Medicine, University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Division of Rheumatic Diseases, National Center for Global Health and Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kaneko","sequence":"additional","affiliation":[{"name":"Division of Rheumatic Diseases, National Center for Global Health and Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,11,25]]},"reference":[{"key":"2021051419010939900_keaa608-B1","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/art.27405","article-title":"Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study","volume":"62","author":"Bongartz","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2021051419010939900_keaa608-B2","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1164\/rccm.200703-463PP","article-title":"Acute exacerbations of idiopathic pulmonary fibrosis","volume":"176","author":"Collard","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"2021051419010939900_keaa608-B3","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1378\/chest.103.6.1808","article-title":"Acute exacerbation in idiopathic pulmonary fibrosis. Analysis of clinical and pathologic findings in three cases","volume":"103","author":"Kondoh","year":"1993","journal-title":"Chest"},{"key":"2021051419010939900_keaa608-B4","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.rmed.2008.12.019","article-title":"Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases","volume":"103","author":"Suda","year":"2009","journal-title":"Respir Med"},{"key":"2021051419010939900_keaa608-B5","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1378\/chest.07-0323","article-title":"Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis","volume":"132","author":"Park","year":"2007","journal-title":"Chest"},{"key":"2021051419010939900_keaa608-B6","doi-asserted-by":"crossref","first-page":"e003132","DOI":"10.1136\/bmjopen-2013-003132","article-title":"Acute exacerbation in rheumatoid arthritis-associated interstitial lung disease: a retrospective case control study","volume":"3","author":"Hozumi","year":"2013","journal-title":"BMJ Open"},{"key":"2021051419010939900_keaa608-B7","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3109\/14397595.2016.1173816","article-title":"Efficacy of intensive immunosuppression in exacerbated rheumatoid arthritis-associated interstitial lung disease","volume":"27","author":"Ota","year":"2017","journal-title":"Mod Rheumatol"},{"key":"2021051419010939900_keaa608-B8","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.reuma.2011.12.008","article-title":"Interstitial lung disease related to rheumatoid arthritis: evolution after treatment","volume":"8","author":"Rojas-Serrano","year":"2012","journal-title":"Reumatol Clin"},{"key":"2021051419010939900_keaa608-B9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"2021051419010939900_keaa608-B10","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2021051419010939900_keaa608-B11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/rheumatology\/keg466","article-title":"Reducing the risk of methotrexate pneumonitis in rheumatoid arthritis","volume":"43","author":"Saravanan","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"2021051419010939900_keaa608-B12","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1002\/art.1780401016","article-title":"Clinical, laboratory, radiographic, and histopathologic features of methotrexate-associated lung injury in patients with rheumatoid arthritis: a multicenter study with literature review","volume":"40","author":"Kremer","year":"1997","journal-title":"Arthritis Rheum"},{"key":"2021051419010939900_keaa608-B13","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management","volume":"183","author":"Raghu","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2021051419010939900_keaa608-B14","first-page":"103","article-title":"Clinical course and outcome of rheumatoid arthritis-related usual interstitial pneumonia","volume":"30","author":"Song","year":"2013","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2021051419010939900_keaa608-B15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/archinternmed.2007.59","article-title":"Progressive preclinical interstitial lung disease in rheumatoid arthritis","volume":"168","author":"Gochuico","year":"2008","journal-title":"Arch Intern Med"},{"key":"2021051419010939900_keaa608-B16","first-page":"1927","article-title":"Methotrexate is not associated with progression of interstitial lung disease in rheumatoid arthritis","volume":"168","author":"Gaffo","year":"2008","journal-title":"Arch Intern Med"},{"key":"2021051419010939900_keaa608-B17","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1080\/03009740601153774","article-title":"Rheumatoid arthritis treatment and the risk of severe interstitial lung disease","volume":"36","author":"Wolfe","year":"2007","journal-title":"Scand J Rheumatol"},{"key":"2021051419010939900_keaa608-B18","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/rheumatology\/41.3.262","article-title":"Investigation of the chronic pulmonary effects of low-dose oral methotrexate in patients with rheumatoid arthritis: a prospective study incorporating HRCT scanning and pulmonary function tests [published correction appears in Rheumatology (Oxford) 2002 May; 41(5):597]","volume":"41","author":"Dawson","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"2021051419010939900_keaa608-B19","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/rheumatology\/keq035","article-title":"Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort","volume":"49","author":"Koduri","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"2021051419010939900_keaa608-B20","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00296-010-1665-1","article-title":"The clinical significance of HRCT in evaluation of patients with rheumatoid arthritis-associated interstitial lung disease: a report from China","volume":"32","author":"Zou","year":"2012","journal-title":"Rheumatol Int"},{"key":"2021051419010939900_keaa608-B21","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s10067-015-3025-8","article-title":"Clinical and laboratory factors associated with interstitial lung disease in rheumatoid arthritis","volume":"34","author":"Restrepo","year":"2015","journal-title":"Clin Rheumatol"},{"key":"2021051419010939900_keaa608-B22","doi-asserted-by":"crossref","first-page":"e028466","DOI":"10.1136\/bmjopen-2018-028466","article-title":"Is incident rheumatoid arthritis interstitial lung disease associated with methotrexate treatment? Results from a multivariate analysis in the ERAS and ERAN inception cohorts","volume":"9","author":"Kiely","year":"2019","journal-title":"BMJ Open"},{"key":"2021051419010939900_keaa608-B23","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1002\/art.38733","article-title":"Methotrexate and lung disease in rheumatoid arthritis: comment on the article by Conway et al","volume":"66","author":"Rojas-Serrano","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2021051419010939900_keaa608-B24","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1093\/rheumatology\/kez337","article-title":"Methotrexate and interstitial lung disease: controversies and questions. A narrative review of the literature","volume":"58","author":"Fragoulis","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"2021051419010939900_keaa608-B25","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/rheumatology\/kez177","article-title":"The lung in a cohort of rheumatoid arthritis patients\u2014an overview of different types of involvement and treatment","volume":"58","author":"Duarte","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"2021051419010939900_keaa608-B26","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1378\/chest.09-0444","article-title":"Rheumatoid arthritis\u2013associated interstitial lung disease: the relevance of histopathologic and radiographic pattern","volume":"136","author":"Kim","year":"2009","journal-title":"Chest"},{"key":"2021051419010939900_keaa608-B27","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3904\/kjim.2016.349","article-title":"Clinical characteristics associated with occurrence and poor prognosis of interstitial lung disease in rheumatoid arthritis","volume":"34","author":"Yang","year":"2019","journal-title":"Korean J Intern Med"},{"key":"2021051419010939900_keaa608-B28","first-page":"344","article-title":"Patterns of interstitial lung disease and mortality in rheumatoid arthritis","volume":"56","author":"Zamora-Legoff","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"2021051419010939900_keaa608-B29","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3899\/jrheum.101261","article-title":"High levels of anti-cyclic citrullinated peptide autoantibodies are associated with co-occurrence of pulmonary diseases with rheumatoid arthritis","volume":"38","author":"Aubart","year":"2011","journal-title":"J Rheumatol"},{"key":"2021051419010939900_keaa608-B30","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.rmed.2012.07.006","article-title":"Different risk factors between interstitial lung disease and airway disease in rheumatoid arthritis","volume":"106","author":"Mori","year":"2012","journal-title":"Respir Med"},{"key":"2021051419010939900_keaa608-B31","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/s41584-019-0275-x","article-title":"Mechanisms of lung disease development in rheumatoid arthritis","volume":"15","author":"Wang","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"2021051419010939900_keaa608-B32","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1801562","article-title":"MUC5B promoter variant and rheumatoid arthritis with interstitial lung disease","volume":"379","author":"Juge","year":"2018","journal-title":"N Engl J Med"},{"key":"2021051419010939900_keaa608-B33","doi-asserted-by":"crossref","first-page":"170050","DOI":"10.1183\/16000617.0050-2017","article-title":"Recent lessons learned in the management of acute exacerbation of idiopathic pulmonary fibrosis","volume":"26","author":"Kondoh","year":"2017","journal-title":"Eur Respir Rev"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/5\/2348\/37936008\/keaa608.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/5\/2348\/37936008\/keaa608.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T19:02:21Z","timestamp":1621018941000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/5\/2348\/6006315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,25]]},"references-count":33,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,11,25]]},"published-print":{"date-parts":[[2021,5,14]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa608","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,5,1]]},"published":{"date-parts":[[2020,11,25]]}}}